{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:37:42Z","timestamp":1787729862453,"version":"build-2784847793"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bone.2012.10.008","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T03:08:07Z","timestamp":1350356887000},"page":"222-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications"],"prefix":"10.1016","volume":"54","author":[{"given":"Katherine","family":"Wesseling-Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.bone.2012.10.008_bb0010","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.bone.2012.10.008_bb0015","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bone.2012.10.008_bb0025","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0045","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.bone.2012.10.008_bb0050","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.bone.2012.10.008_bb0055","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.bone.2012.10.008_bb0060","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0065","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.bone.2012.10.008_bb0070","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"113","key":"10.1016\/j.bone.2012.10.008_bb0075","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0080","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0085","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","article-title":"Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4","volume":"301","author":"Gattineni","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7120","key":"10.1016\/j.bone.2012.10.008_bb0090","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.bone.2012.10.008_bb0100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.bone.2012.10.008_bb0105","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.bone.2012.10.008_bb0110","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0115","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency","volume":"73","author":"Portale","year":"1984","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0125","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bone.2012.10.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5414\/CNP62432","article-title":"High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis","volume":"62","author":"Lobao","year":"2004","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1016\/j.bone.2012.10.008_bb0145","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.2215\/CJN.01330210","article-title":"Value of the new bone classification system in pediatric renal osteodystrophy","volume":"5","author":"Bakkaloglu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1677\/joe.0.0640573","article-title":"A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture","volume":"64","author":"Atkins","year":"1975","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/8756-3282(93)90162-4","article-title":"In situ localization of PTH\/PTHrP receptor mRNA in the bone of fetal and young rats","volume":"14","author":"Lee","year":"1993","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2012.10.008_bb0160","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0170","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7\u201384)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0175","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bone.2008.07.250","article-title":"Differential effects of intermittent PTH(1\u201334) and PTH(7\u201334) on bone microarchitecture and aortic calcification in experimental renal failure","volume":"43","author":"Sebastian","year":"2008","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","article-title":"Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD","volume":"53","author":"Kuizon","year":"1998","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.bone.2012.10.008_bb0190","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000057384","article-title":"Intermittent calcitriol therapy and growth in children with chronic renal failure","volume":"24","author":"Kuizon","year":"1998","journal-title":"Miner Electrolyte Metab"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2012.10.008_bb0205","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.10.008_bb0210","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","author":"Wesseling-Perry","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0215","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bone.2004.08.004","article-title":"Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder?","volume":"35","author":"Munns","year":"2004","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1523-1755.2003.00727.x","article-title":"Severe bone disease and low bone mineral density after juvenile renal failure","volume":"63","author":"Groothoff","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00774-007-0788-2","article-title":"Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate[corrected]: an improved method for immunohistochemistry","volume":"26","author":"Gomes","year":"2008","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0235","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1152\/ajpendo.90201.2008","article-title":"Pathogenic role of Fgf23 in Dmp1-null mice","volume":"295","author":"Liu","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0245","doi-asserted-by":"crossref","first-page":"e32177","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp1(\u2212\/\u2212) mice","volume":"7","author":"Mackenzie","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0250","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2013an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0255","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"issue":"5 Suppl. 3","key":"10.1016\/j.bone.2012.10.008_bb0260","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1016\/j.bone.2012.10.008_bb0265","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0275","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","article-title":"Soft tissue calcification in pediatric patients with end-stage renal disease","volume":"38","author":"Milliner","year":"1990","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0280","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1681\/ASN.2004110932","article-title":"Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation","volume":"16","author":"Litwin","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0285","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.2002.00472.x","article-title":"Cardiovascular disease in pediatric chronic dialysis patients","volume":"62","author":"Chavers","year":"2002","journal-title":"Kidney Int"},{"issue":"17","key":"10.1016\/j.bone.2012.10.008_bb0290","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0300","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","article-title":"Coronary artery calcification in patients with CRF not undergoing dialysis","volume":"44","author":"Russo","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0305","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5414\/CNP63146","article-title":"Mechanisms of vascular calcification in renal disease","volume":"63","author":"Shanahan","year":"2005","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0315","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0320","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","article-title":"Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels","volume":"63","author":"Moe","year":"2003","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.bone.2012.10.008_bb0325","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0330","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/ATVBAHA.106.132266","article-title":"Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification","volume":"27","author":"Villa-Bellosta","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0335","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","article-title":"Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells","volume":"37","author":"Ahmed","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"2A","key":"10.1016\/j.bone.2012.10.008_bb0340","doi-asserted-by":"crossref","first-page":"20E","DOI":"10.1016\/S0002-9149(01)01718-0","article-title":"Insights into the mechanism of vascular calcification","volume":"88","author":"Bostrom","year":"2001","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0345","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0350","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","article-title":"Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells","volume":"62","author":"Chen","year":"2002","journal-title":"Kidney Int"},{"issue":"34","key":"10.1016\/j.bone.2012.10.008_bb0355","doi-asserted-by":"crossref","first-page":"20789","DOI":"10.1074\/jbc.271.34.20789","article-title":"The serum protein alpha2-HS glycoprotein\/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis","volume":"271","author":"Schinke","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0360","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1538-7836.2003.00023.x","article-title":"Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats","volume":"1","author":"Sweatt","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0365","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.bone.2012.10.008_bb0370","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0375","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fj.05-5432fje","article-title":"Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process","volume":"20","author":"Razzaque","year":"2006","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.bone.2012.10.008_bb0380","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-011-1822-0","article-title":"Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients","volume":"26","author":"Srivaths","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"18","key":"10.1016\/j.bone.2012.10.008_bb0385","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to FGF-23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bone.2012.10.008_bb0390","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.bone.2012.10.008_bb0395","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bone.2012.10.008_bb0400","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.bone.2012.10.008_bb0405","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","article-title":"Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats","volume":"69","author":"Nagano","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2012.10.008_bb0410","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continous PTH(1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7\u201384)","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bone.2012.10.008_bb0415","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.bone.2012.10.008_bb0420","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bone.2012.10.008_bb0425","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.bone.2012.10.008_bb0430","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/ndt\/gfr384","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism","volume":"27","author":"Koizumi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.bone.2012.10.008_bb0435","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","article-title":"The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease","volume":"95","author":"Bacchetta","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212013166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212013166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T18:02:00Z","timestamp":1562263320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328212013166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S8756328212013166"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2012.10.008","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2012.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}